Now that IMS is no longer a Wencor target, and since their PEA has had lukewarm acceptance, who is to say they wouldn`t be switching to a version of the MedeViewer.

And wouldn`t that be an option for all of those companies looking to penetrate this market? Why reinvent the wheel when EDIG can just build the next generation player upon their original platform?

I wonder what those ``emerging`` IFE deals are all about.

``I am more confident than ever about our prospects for business and revenue growth,” concluded Anandpura. “Based on current and emerging business,``